Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Nature Communications, 2024
Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank

Papier K., Atkins J., Tong T. et al.

Olink Explore 3072/384OncologyPathophysiologyPatient StratificationPlasma

Frontiers in Psychiatry, 2024
Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts

Sokolov A., Lafta M., Nordberg D. et al.

Olink Target 96NeurologyPatient StratificationPlasma

EMBO Molecular Medicine, 2024
Electron transport chain capacity expands yellow fever vaccine immunogenicity

Mok D., Tng D., Yee J. et al.

Olink Target 48Infectious DiseasesPathophysiologyPlasma

Journal of the Neurological Sciences, 2024
Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation

Jakimovski D., Qureshi F., Ramanathan M. et al.

Olink FocusNeurologyPatient StratificationSerum

JAMA Network Open, 2024
Cord Blood Proteomic Profiles, Birth Weight, and Early Life Growth Trajectories

Van Pee T., Martens D., Alfano R. et al.

Olink Explore 3072/384ObstetricsPathophysiologyPatient StratificationCord Blood

Cell Genomics, 2024
Ribosomal DNA copy number variation associates with hematological profiles and renal function in the UK Biobank

Rodriguez-Algarra F., Evans D., Rakyan V.

Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma

Alzheimer's Research & Therapy, 2024
Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy

Vervuurt M., Kuiperij H., de Kort A. et al.

Olink Explore 3072/384NeurologyPatient StratificationCSF

Journal of Allergy and Clinical Immunology, 2024
Loss of the TRPM4 channel in humans causes immune dysregulation with defective monocyte migration

Yu F., Hubrack S., Raynaud C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

Clinical and Translational Medicine, 2024
Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial

Man X., Huang J., Sun S. et al.

Olink Target 96OncologyPathophysiologyPlasma

JHLT Open, 2024
Proteomics early after heart transplantation and relation to coronary intimal changes and prognosis

Dalsgaard R., Clemmensen T., Eiskjær H. et al.

Olink Target 96CVDPatient StratificationPlasma

BMC Medicine, 2024
Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank

Wang X., Shi Z., Qiu Y. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Clinical Immunology, 2024
Serum proteomics reveals hemophagocytic lymphohistiocytosis-like phenotype in a subset of patients with multisystem inflammatory syndrome in children

Tulling A., Holierhoek M., Jansen-Hoogendijk A. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologyPatient StratificationSerum

PROTEOMICS – Clinical Applications, 2024
Methods and clinical biomarker discovery for targeted proteomics using Olink technology

Wang H., Zhao T., Zeng J. et al.

Wider Proteomics StudiesReview/editorial

Immunology & Cell Biology, 2024
Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation

Alexandersson A., Venäläinen M., Heikkilä N. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

Frontiers in Immunology, 2024
Plasma proteomics analysis of Chinese HIV-1 infected individuals focusing on the immune and inflammatory factors afford insight into the viral control mechanism

Ni W., Ren L., Liao L. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

BMJ Oncology, 2024
First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours

Naing A., Papadopoulos K., Pishvaian M. et al.

Olink Target 96OncologyPathophysiologyPlasma

Ticks and Tick-borne Diseases, 2024
Diagnostic patterns of serum inflammatory protein markers in children with Lyme neuroborreliosis

Fredriksson T., Brudin L., Henningsson A. et al.

Olink Target 96Infectious DiseasesPatient StratificationSerum

Biomolecules, 2024
GlycA and CRP Are Genetically Correlated: Insight into the Genetic Architecture of Inflammageing

Kasher M., Freidin M., Williams F. et al.

Olink Target 96Immunological & Inflammatory DiseasesAgingPathophysiologyBlood

Journal of the European Academy of Dermatology and Venereology, 2024
Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis

Soenen R., Schots L., Wang Z. et al.

Olink Target 96Dermatological DiseasesPatient StratificationSerum

Clinical Immunology, 2024
Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestation

Reiter A., Verweyen E., Queste E. et al.

Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologySerum

3247 publications